Conference Coverage
Conference Coverage
Breast milk doesn’t contain meaningful levels of certolizumab pegol
WASHINGTON – Certolizumab pegol is not transmitted into human breast milk in any clinically meaningful level, a postmarketing pharmacokinetic...
Conference Coverage
Risk stratification important for aortic valve disease in pregnancy
CHICAGO – Understanding pregnancy’s toll on the body can help physicians treat aortic stenosis or aortic regurgitation in pregnant women.
Conference Coverage
Multidose metronidazole may be better option for trichomoniasis treatment
Current CDC guidance recommends multidose treatment only for women with HIV, but findings from a meta-analysis suggest all women with...
Conference Coverage
Infectious disease physicians: Antibiotic shortages are the new norm
Antibiotic shortages are now a way of life, and physicians report that shortages are affecting patient care and outcomes.
Conference Coverage
Nutraceutical cocktail protects against postpartum blues
VIENNA – The postpartum blues, a common prodrome for postpartum depression, may be preventable by means of a dietary supplement.
Conference Coverage
Study offers reassuring data on certolizumab use in pregnancy
VIENNA – Consider off-label certolizumab in women with psoriasis who need a biologic and are pregnant or planning to become so.
Conference Coverage
Nonsurgical biomarkers show potential in chronic endometriosis
SALT LAKE CITY - Certain nonsurgical biomarkers appear to accurately identify chronic endometriosis and might soon spare patients from years of...
Conference Coverage
Expert tips for working with aspiring LGBT parents
SALT LAKE CITY – LGBT individuals face legal obstacles on the road to parenthood via assisted reproductive technology.
Conference Coverage
Obese IVF patients need higher HCG trigger dose
SALT LAKE CITY - Women who are obese should receive more than 5,000 IU of human chorionic gonadotropin (HCG) to trigger final oocyte maturation...
Conference Coverage
Ulipristal acetate meets primary endpoint in pivotal uterine fibroids trial
SALT LAKE CITY
Conference Coverage
Balancing speed, safety in device approvals
WASHINGTON – The Food and Drug Administration is looking for ways to make changes in the drug approval process to allow for quicker approval times...